- ►202.149.114.180 [PDF] - Free from Publisher BGA Stuckey, MN Jadzinsky, LJ Murphy, F … - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS—Improvements in mean scores from baseline to end-of-treatment for IIEF
Q3 (35.7 vs. 19.9%) and Q4 (68.4 vs. 26.5%) were significant in patients
receiving sildenafil compared with those receiving placebo (P = 0.0001). ... Cited by 91 - Related articles - BL Direct - All 6 versions
AJM Boulton, JL Selam, M Sweeney, D … - Diabetologia, 2001 - Springer 90% to 95% of the diagnosed patients [1]. A frequent complication of diabetes is
erectile dysfunction (ED), with an estimated prevalenceof 20% to 85% (ranging
from mild to complete ED) [2], which occurs at an ear- lier age than in non- ... Cited by 109 - Related articles - BL Direct - All 3 versions
- Free from Publisher S de Tejada… - Diabetes Care, 2002 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Men with type 1 or type 2 diabetes and a minimum
3-month history of ED were randomly allocated to one of three groups: placebo (n
= 71), tadalafil 10 mg (n = 73), or tadalafil 20 mg (n = 72) taken up to ... Cited by 178 - Related articles - BL Direct - All 5 versions
JM Young, C Bennett, P Gilhooly, H … - Urology, 2002 - Elsevier The objective of this study was to assess the efficacy and safety of sildenafil
citrate (Viagra) in black American and Hispanic American men with erectile
dysfunction (ED) of broad-spectrum etiology. A total of 246 black American ... Cited by 44 - Related articles - All 8 versions
- ►diabetesjournals.org I Goldstein, JM Young, J Fischer, K Bangerter, … - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS—After 12 weeks of treatment, a dose-dependent (P = 0.02) improvement
in erections was noted for the GAQ, with 57 and 72% of men taking 10 mg or 20 mg
vardenafil, respectively, reporting improved erections, in contrast to 13% ... Cited by 184 - Related articles - BL Direct - All 5 versions
AM Olsson, CA Persson - International journal of clinical practice(Esher), 2001 - cat.inist.fr Men with cardiovascular disease(CVD) are more likely to have erectile
dysfunction(ED) than the general population, as both conditions share risk
factors and some drugs used to treat CVD may induce ED as a side-effect. ... Cited by 55 - Related articles - BL Direct - All 3 versions
TG Pickering, AMM Shepherd, I Puddey, DB … - American journal of hypertension, 2004 - Elsevier A total of 562 men (mean age, 59 years) took ≥1 dose of study drug. At week 6,
mean scores on both Q3 and Q4 improved significantly among sildenafil-treated
compared with placebo-treated patients. In regard to Q3 and Q4 there were ... Cited by 42 - Related articles - All 5 versions
MS Rendell, J Rajfer, PA Wicker, MD Smith - Jama, 1999 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 352 - Related articles - BL Direct - All 4 versions
RF DeBusk, CJ Pepine, DB Glasser, A … - The American journal of cardiology, 2004 - Elsevier This was a double-blind, placebo-controlled, flexible-dose study of the efficacy
and safety of sildenafil in men with erectile dysfunction (ED) and clinically
stable coronary artery disease (CAD). Patients were randomized to receive ... Cited by 64 - Related articles - All 10 versions
- ►psychiatryonline.org SN Seidman, SP Roose, MA Menza, R … - American Journal of Psychiatry, 2001 - Am Psychiatric Assoc OBJECTIVE: Depressed men commonly have erectile dysfunction, and men with
erectile dysfunction are frequently depressed. Since the etiologic and
modulatory relationships between depression and erectile dysfunction have ... Cited by 162 - Related articles - BL Direct - All 6 versions
